Ossovskaya VS, Bunnett NW. Protease-activated receptors: contribution to physiology and disease. Physiol Rev. 2004;84:579–621.
CAS PubMed Article Google Scholar
Alberelli MA, de Candia E. Functional role of protease activated receptors in vascular biology. Vasc Pharmacol. 2014;62:72–81.
Zhao P, Metcalf M, Bunnett NW. Biased signaling of protease-activated receptors. Front Endocrinol. 2014;5:89.
Han X, Nieman MT. The domino effect triggered by the tethered ligand of the protease activated receptors. Thrombosis Res. 2020;196:89.
Soto AG, Smith TH, Chen B, Bhattacharya S, Cordova IC, Kenakin T, et al. N-linked glycosylation of protease-activated receptor-1 at extracellular loop 2 regulates G-protein signaling bias. Proc Natl Acad Sci U S A. 2015;112:27.
Vu TKH, Hung DT, Wheaton VI, Coughlin SR. Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell. 1991;64:6.
Ishihara H, Connolly AJ, Zeng D, Kahn ML, Zheng YW, Timmons C, et al. Protease-activated receptor 3 is a second thrombin receptor in humans. Nature. 1997;386:6624.
Xu WF, Andersen H, Whitmore TE, Presnell SR, Yee DP, Ching A, et al. Cloning and characterization of human protease-activated receptor 4. Proc Natl Acad Sci U S A. 1998;95:12.
Nystedt S, Emilsson K, Wahlestedt C, Sundelin J. Molecular cloning of a potential proteinase activated receptor. Proc Natl Acad Sci. 1994;91(20):9208–12.
CAS PubMed PubMed Central Article Google Scholar
Bai M. Dimerization of G-protein-coupled receptors: roles in signal transduction. Cell Signal. 2004;16(2):175–86.
CAS PubMed Article Google Scholar
Lin H, Liu AP, Smith TH, Trejo JA. Cofactoring and dimerization of proteinase-activated receptors. Pharmacol Rev. 2013;65(4):1198–213.
CAS PubMed PubMed Central Article Google Scholar
Gieseler F, Ungefroren H, Settmacher U, Hollenberg MD, Kaufmann R. Proteinase-activated receptors (PARs) - Focus on receptor-receptor- interactions and their physiological and pathophysiological impact. Cell Commun Signal. 2013;11:78.
Leger AJ, Jacques SL, Badar J, Kaneider NC, Derian CK, Andrade-Gordon P, et al. Blocking the protease-activated receptor 1–4 heterodimer in platelet-mediated thrombosis. Circulation. 2006;113(9):1244–54.
CAS PubMed Article Google Scholar
Kaneider NC, Leger AJ, Agarwal A, Nguyen N, Perides G, Derian C, et al. “Role reversal” for the receptor PAR1 in sepsis-induced vascular damage. Nat Immunol. 2007;8(12):1303–12.
CAS PubMed PubMed Central Article Google Scholar
Chandrabalan A, Ramachandran R. Molecular mechanisms regulating Proteinase-Activated Receptors (PARs). FEBS J. 2021;288(8):2697–726. https://doi.org/10.1111/febs.15829.
CAS Article PubMed Google Scholar
McLaughlin JN, Shen L, Holinstat M, Brooks JD, DiBenedetto E, Hamm HE. Functional selectivity of G protein signaling by agonist peptides and thrombin for the protease-activated receptor-1. J Biol Chem. 2005;280(26):25048–59.
CAS PubMed Article Google Scholar
de la Fuente M, Han X, Miyagi M, Nieman MT. Expression and purification of protease-activated receptor 4 (PAR4) and analysis with histidine hydrogen-deuterium exchange. Biochemistry. 2020;59(5):671–81. https://doi.org/10.1021/acs.biochem.9b00987.
CAS Article PubMed Google Scholar
Nakanishi-Matsui M, Zheng YW, Sulciner DJ, Welss EJ, Ludeman MJ, Coughlin SR. PAR3 is a cofactor for PAR4 activation by thrombin. Nature. 2000;404(6778):609–13.
CAS PubMed Article Google Scholar
Kahn ML, Nakanishi-Matsui M, Shapiro MJ, Ishihara H, Coughlin SR. Protease-activated receptors 1 and 4 mediate activation of human platelets by thrombin. J Clin Investig. 1999;103:6.
Blackhart BD, Emilsson K, Nguyen D, Teng W, Martelli AJ, Nystedt S, et al. Ligand cross-reactivity within the protease-activated receptor family. J Biol Chem. 1996;271(28):16466–71.
CAS PubMed Article Google Scholar
Sevigny LM, Austin KM, Zhang P, Kasuda S, Koukos G, Sharifi S, et al. Protease-activated receptor-2 modulates protease-activated receptor-1-driven neointimal hyperplasia. Arterioscler Thromb Vasc Biol. 2011;31:12.
Chen J, Ishii M, Wang L, Ishii K, Coughlin S. Thrombin receptor activation. Confirmation of the intramolecular tethered liganding hypothesis and discovery of an alternative intermolecular liganding mode. J Biol Chem. 1994;269(23):16041–5.
CAS PubMed Article Google Scholar
Sevigny LM, Zhang P, Bohm A, Lazarides K, Perides G, Covic L, et al. Interdicting protease-activated receptor-2-driven inflammation with cell-penetrating pepducins. Proc Natl Acad Sci U S A. 2011;108(20):8491–6.
CAS PubMed PubMed Central Article Google Scholar
McLaughlin JN, Patterson MM, Malik AB. Protease-activated receptor-3 (PAR3) regulates PAR1 signaling by receptor dimerization. Proc Natl Acad Sci U S A. 2007;104(13):5662–7.
CAS PubMed PubMed Central Article Google Scholar
de La Fuente M, Noble DN, Verma S, Nieman MT. Mapping human Protease-activated Receptor 4 (PAR4) homodimer interface to transmembrane helix 4. J Biol Chem. 2012;287:13.
Arachiche A, Mumaw MM, de La Fuente M, Nieman MT. Protease-activated receptor 1 (PAR1) and PAR4 heterodimers are required for PAR1-enhanced cleavage of PAR4 by α-thrombin. J Biol Chem. 2013;288(45):32553–62.
CAS PubMed PubMed Central Article Google Scholar
Little PJ, Burch ML, Al-aryahi S, Zheng W. The paradigm of G protein receptor transactivation: a mechanistic definition and novel example. Scientific World J. 2011;11:709–14.
Cunningham MR, McIntosh KA, Pediani JD, Robben J, Cooke AE, Nilsson M, et al. Novel role for proteinase-activated receptor 2 (PAR2) in membrane trafficking of proteinase-activated receptor 4 (PAR4). J Biol Chem. 2012;287:20.
Bah A, Chen Z, Bush-Pelc LA, Mathews FS, di Cera E. Crystal structures of murine thrombin in complex with the extracellular fragments of murine protease-activated receptors PAR3 and PAR4. Proc Natl Acad Sci U S A. 2007;104(28):11603–8.
CAS PubMed PubMed Central Article Google Scholar
Arachiche A, de la Fuente M, Nieman MT. Calcium mobilization and protein kinase c activation downstream of protease activated receptor 4 (PAR4) is negatively regulated by PAR3 in mouse platelets. PLoS ONE. 2013;8:2.
Covic L, Gresser AL, Kuliopulos A. Biphasic kinetics of activation and signaling for PAR1 and PAR4 thrombin receptors in platelets. Biochemistry. 2000;39:18.
Shapiro MJ, Weiss EJ, Faruqi TR, Coughlin SR. Protease-activated receptors 1 and 4 are shut off with distinct kinetics after activation by thrombin. J Biol Chem. 2000;275:33.
Holinstat M, Voss B, Bilodeau ML, McLaughlin JN, Cleator J, Hamm HE. PAR4, but not PAR1, signals human platelet aggregation via Ca2+ mobilization and synergistic P2Y12 receptor activation. J Biol Chem. 2006;281(36):26665–74.
CAS PubMed Article Google Scholar
Sveshnikova AN, Balatskiy A, Demianova AS, Shepelyuk TO, Shakhidzhanov SS, Balatskaya MN, et al. Systems biology insights into the meaning of the platelet’s dual-receptor thrombin signaling. J Thromb Haemost. 2016;14(10):2045–57.
CAS PubMed Article Google Scholar
Shankar H, Garcia A, Prabhakar J, Kim S, Kunapuli SP. P2Y12 receptor-mediated potentiation of thrombin-induced thromboxane A2 generation in platelets occurs through regulation of Erk1/2 activation. J Thromb Haemost. 2006;4(3):638–47.
CAS PubMed Article Google Scholar
Khan A, Li D, Ibrahim S, Smyth E, Woulfe DS. The physical association of the P2Y12 receptor with PAR4 regulates arrestin-mediated akt activation. Mol Pharmacol. 2014;86(1):1–11.
PubMed PubMed Central Article CAS Google Scholar
O’Brien PJ, Prevost N, Molino M, Hollinger MK, Woolkalis MJ, Woulfe DS, et al. Thrombin responses in human endothelial cells. Contributions from receptors other than PAR1 include the transactivation of PAR2 by thrombin-cleaved PAR1. J Biol Chem. 2000;275(18):13502–9.
Lin H, Trejo J. Transactivation of the PAR1-PAR2 heterodimer by thrombin elicits β-arrestin-mediated endosomal signaling. J Biol Chem. 2013;288(16):11203–15.
CAS PubMed PubMed Central Article Google Scholar
Komarova YA, Mehta D, Malik AB. Dual regulation of endothelial junctional permeability. Science. 2007;2007:67.
Feistritzer C, Lenta R, Riewald M. Protease-activated receptors-1 and -2 can mediate endothelial barrier protection: Role in factor Xa signaling. J Thromb Haemost. 2005;3:12.
El-Daly M, Saifeddine M, Mihara K, Ramachandran R, Triggle CR, Hollenberg MD. Proteinase-activated receptors 1 and 2 and the regulation of porcine coronary artery contractility: A role for distinct tyrosine kinase pathways. Br J Pharmacol. 2014;171(9):2413–25.
留言 (0)